Genomind

An article discussing pharmacotherapy for generalized anxiety disorder and how pharmacogenetic testing can help personalize treatment.

A snapshot of how Americans treat their mental health conditions and the associated costs.

Dr. Bruce Kehr explains the benefits of genetic testing in psychiatry and why he recommends it for his patients.

A guide to meditation for improving focus and reducing stress, anxiety, and depression.

Dr. Christopher Bojrab discusses the mental health challenges faced by athletes and the benefits of Genomind’s genetic test, Genecept Assay.

An overview of medication options for anxiety and how to determine which one may be best for you.

Learn more about the mood stabilizer lithium and how to manage common side effects of the medication.

Explores the link between allergies and depression, highlighting that those with allergies are nearly 50% more likely to experience depression.

A guide to understanding seasonal affective disorder and practical tips to manage its symptoms.

Genomind President and CEO Michael Koffler shares his thoughts on the importance of Mental Health Month in May.

Glenn Close and Patrick Kennedy discuss their personal experiences with mental illness and advocate for better mental health awareness.

Researchers are working to see how effective light therapy may be for those struggling with bipolar depression. Learn more on the Genomind Blog.

During Men’s Health Month in June, take the time to learn about life-saving resources and read stories from men who are dealing with depression.

Royals Launch Mental Health Film Series with Heads Together Campaign.

Learn about the signs and symptoms of living with generalized anxiety disorder on the Genomind Blog.

A genetic testing patient success story retold in the subject’s own words.

Explores why teenage girls experience depression at higher levels than boys their age, including the role of constant online connection.

A patient story about how the Genecept Assay® genetic test helped inform medication decisions for better outcomes.

Watch Genomind's webinar in recognition of Mental Health Awareness Month, discussing genetic variations associated with psychotropic drug response and side effects.

Dr. Phil talks about how the Genomind pharmacogenetic (PGx) test can help patients with mental health conditions, such as depression, anxiety, or ADHD.

A guide for patients and caregivers on how telemedicine and telehealth appointments can help those struggling with depression, anxiety, or other mental health issues.

Seasonal affective disorder (SAD) is more than just winter blues. It is a type of depression that is related to the change in seasons, and it is treatable.

Many children and teens with ADHD or depression often also have another mental health condition. Here’s what parents should know about comorbidities.

If you’re a parent or caregiver to someone with a mental health condition, it’s important to take care of yourself to avoid caregiver burnout.

Learn more about the HLA-A and HLA-B genes and how genetic variability can increase an individual’s risk of developing an immune-mediated drug hypersensitivity reaction.

Genomind and guest speaker, Dr. Ruth Benca, MD, PhD, present Sleep, Rhythms, and Genetics in Psychiatry.

When U.S. figure skater Gracie Gold announced she would be taking a break to focus on her mental health, she showed the world the importance of putting yourself first.

Learn about the importance of screening for symptoms to assist with a proper treatment for adult ADHD. The Genomind Blog shares more here.

If your kid or teen needs mental health help and there’s no child psychiatrist in your area, don’t give up. Try these strategies find resources.

Not all treatments for depression work on everyone. Learn about treatment-resistant depression causes, criteria and treatment options.

For years, William had been on a roller coaster ride of conventional mental health treatment to improve his anxiety and depression symptoms. This article discusses how genetic testing can help clarify diagnosis and care.

Exploring the different types of bipolar disorder and how genetic testing can inform diagnosis and treatment.

Five key facts about major depressive disorder, its symptoms, and treatment options.

Genomind announces the launch of GenMed Pro™ – Precision Gene-Drug Interaction Software, designed to revolutionize the prescription process for mental health medications.

In recognition of Bipolar Awareness Day, this article answers four common questions about bipolar disorder and addresses common misunderstandings.

Dr. Jay Lombard shares the reasons for co-founding Genomind and discusses the future of genetic testing in mental health.

Genomind launches Genomind Professional PGx Express™, a new, more focused report and set of services to enhance its mental health genetic testing.

Genomind announces the appointment of Rina Wolf to its Board of Directors, strengthening its leadership team.

Genomind partners with ACME pharmacists to identify and work with patients who may benefit from genetic testing services aimed at improving mental health treatments.

Genomind announced a headquarters expansion and its Genecept Assay® has been used to aid clinicians in treating a total of over 100,000 patients.

Shawn O’Brien joined Johnny’s Radio Happy Hour on Sports 56 to explain Mental Health Map, partnering with Kevin Love & why parents should care about their child’s genetics.

Genomind and guest speaker, Dr. Kelly E. Caudle, PharmD, PhD, BCPS, discuss CPIC guidelines.

A webinar for nursing homes on optimizing case management for residents with mental health conditions using genetics-based medication management.

Genomind’s partnership with Evexia Diagnostics expands access to its pharmacogenetic testing, helping more clinicians personalize treatments and improve patient outcomes through genetic insights.

Genomind announces the release of an innovative patient report, providing patients with an easy-to-understand view into their personalized genetic test results.

Kevin Love partners with Genomind to introduce Mental Health Map, a genetic test designed to help people start their mental health and wellness journey.

Join Genomind for a Grand Rounds Clinical Pathological Conference (CPC) Presentation.

Genomind CEO Shawn Patrick O’Brien joins Casey Freelove of KAHI Radio in Sacramento/ Auburn, CA to discuss Genomind’s tests, mission and initiatives.

Learn about psychedelic use in psychiatry from Dr. Cody Wenthur in a Genomind Grand Rounds event.

Join the Genomind Medical Affairs team for a roundtable discussion focused on mental health pharmacogenetics (PGx).

Dr. Jay Lombard of Genomind was selected to speak at TEDMED 2012 on 'The New Map For Mental Illness.'